TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 34074963

Group type: EXPERIMENTAL
Intervention: Neuman Systems Model intervention
Number of subjects: 70

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 70
Study: 35595804

Group type: EXPERIMENTAL
Intervention: Intermittent pneumatic compression (IPC)
Number of subjects: 275

Group type: COMPARATOR
Intervention: Control (pharmacologic thromboprophylaxis alone)
Number of subjects: 275
Study: 33302675

Group type: EXPERIMENTAL
Intervention: Multimodal ultrasound (including two-dimensional ultrasound, Doppler ultrasound, contrast-enhanced ultrasound (CEUS), elastography)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Multimodal ultrasound
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: CEUS and elastography
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Ultrasound and CT
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Ultrasound
Number of subjects: 0
Study: 35370814

Group type: EXPERIMENTAL
Intervention: S‐AII (self-affirming implementation intention)
Number of subjects: 222

Group type: EXPERIMENTAL
Intervention: BS‐AII (body-related self-affirming implementation intention)
Number of subjects: 222

Group type: COMPARATOR
Intervention: MGI (mere goal intention—control condition)
Number of subjects: 222

Group type: EXPERIMENTAL
Intervention: S‐AII + B (booster)
Number of subjects: 222

Group type: EXPERIMENTAL
Intervention: BS‐AII + B (booster)
Number of subjects: 222

Group type: COMPARATOR
Intervention: MGI + B (booster)
Number of subjects: 222
Study: 33320098

Group type: EXPERIMENTAL
Intervention: mEMR usage (frequent users defined as logging in more than once a day)
Number of subjects: 87

Group type: EXPERIMENTAL
Intervention: mEMR usage (frequent users)
Number of subjects: 87
Study: 36398423

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine/remifentanil and low dose sevoflurane anaesthesia
Number of subjects: 32

Group type: COMPARATOR
Intervention: Standard sevoflurane anaesthesia
Number of subjects: 32
Study: 33792111

Group type: EXPERIMENTAL
Intervention: Sea buckthorn cream
Number of subjects: 55

Group type: COMPARATOR
Intervention: 1% silver sulfadiazine (SSD)
Number of subjects: 55
Study: 32194195

Group type: EXPERIMENTAL
Intervention: Transcatheter mitral valve repair (TMVr) with the MitraClip
Number of subjects: 551

Group type: COMPARATOR
Intervention: Guideline-directed medical therapy (GDMT) alone
Number of subjects: 551

Group type: EXPERIMENTAL
Intervention: Change in KCCQ-OS (continuous variable)
Number of subjects: 551

Group type: EXPERIMENTAL
Intervention: Change in KCCQ-OS (after adjusting for demographic and clinical factors)
Number of subjects: 551
Study: 34271337

Group type: EXPERIMENTAL
Intervention: Adverse Childhood Experiences (ACEs)
Number of subjects: 618

Group type: EXPERIMENTAL
Intervention: Childhood Caregiving Environment (CCE) scale
Number of subjects: 618
Study: 35789430

Group type: EXPERIMENTAL
Intervention: Ticagrelor
Number of subjects: 4018

Group type: COMPARATOR
Intervention: Prasugrel
Number of subjects: 4018
Study: 32921130

Group type: EXPERIMENTAL
Intervention: Mental health interventions (not specified)
Number of subjects: 641

Group type: EXPERIMENTAL
Intervention: Physical health interventions (not specified)
Number of subjects: 641

Group type: EXPERIMENTAL
Intervention: Access to general practices
Number of subjects: 641

Group type: COMPARATOR
Intervention: Community rehabilitation, psychosocial interventions, and case management
Number of subjects: 641
Study: 32919912

Group type: EXPERIMENTAL
Intervention: Spironolactone
Number of subjects: 1431

Group type: COMPARATOR
Intervention: Not applicable (control group)
Number of subjects: 1431

Group type: COMPARATOR
Intervention: Not applicable (baseline PHQ-9 scores)
Number of subjects: 1431

Group type: COMPARATOR
Intervention: Not applicable (worsening depressive symptoms)
Number of subjects: 1431
Study: 34160603

Group type: EXPERIMENTAL
Intervention: Intervention group (health education, systematic auscultation, and opportunistic ECG)
Number of subjects: 2231

Group type: EXPERIMENTAL
Intervention: Subgroup A (ECG at each visit)
Number of subjects: 2231

Group type: EXPERIMENTAL
Intervention: Subgroup B (ECG only if arrhythmia detected)
Number of subjects: 2231

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 2231
Study: 33966607

Group type: EXPERIMENTAL
Intervention: mHealth voice messaging intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 33518473

Group type: EXPERIMENTAL
Intervention: Otamixaban
Number of subjects: 8656

Group type: COMPARATOR
Intervention: Unfractionated heparin plus eptifibatide
Number of subjects: 8656

Group type: EXPERIMENTAL
Intervention: Procedural complications
Number of subjects: 8656
Study: 32909702

Group type: EXPERIMENTAL
Intervention: Laser-assisted flapless corticotomy (LAFC)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Piezocision
Number of subjects: 32

Group type: COMPARATOR
Intervention: Both LAFC and piezocision
Number of subjects: 32
Study: 36256638

Group type: EXPERIMENTAL
Intervention: Counseling message addressing user-centered concerns about self-injection (treatment group)
Number of subjects: 24354

Group type: COMPARATOR
Intervention: No counseling message (control group)
Number of subjects: 24354
Study: 33369937

Group type: EXPERIMENTAL
Intervention: NOV03 4 times daily (QID)
Number of subjects: 336

Group type: EXPERIMENTAL
Intervention: NOV03 twice daily (BID)
Number of subjects: 336

Group type: COMPARATOR
Intervention: Saline BID
Number of subjects: 336

Group type: COMPARATOR
Intervention: Saline QID
Number of subjects: 336
Study: 34369566

Group type: EXPERIMENTAL
Intervention: Light force (300 g)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Heavy force (500 g)
Number of subjects: 40
Study: 32916236

Group type: EXPERIMENTAL
Intervention: Photon radiation with chemotherapy
Number of subjects: 178

Group type: COMPARATOR
Intervention: Proton radiation with chemotherapy
Number of subjects: 178

Group type: EXPERIMENTAL
Intervention: Not specified
Number of subjects: 178
Study: 33122694

Group type: EXPERIMENTAL
Intervention: M. officinalis extract containing 500 mg of rosmarinic acid (RA) daily
Number of subjects: 23

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 23
Study: 35102808

Group type: EXPERIMENTAL
Intervention: Treadmill training (40-60% heart rate reserve) and self-management education for 30 minutes, three times a week for 8 weeks
Number of subjects: 119

Group type: EXPERIMENTAL
Intervention: Treadmill training and self-management education
Number of subjects: 119
Study: 36202695

Group type: EXPERIMENTAL
Intervention: Stable hospice
Number of subjects: 24342

Group type: EXPERIMENTAL
Intervention: SMSCS only
Number of subjects: 24342

Group type: EXPERIMENTAL
Intervention: Decreasing intensity
Number of subjects: 24342

Group type: EXPERIMENTAL
Intervention: CDT or concurrent care
Number of subjects: 24342

Group type: EXPERIMENTAL
Intervention: Increasing intensity
Number of subjects: 24342

Group type: COMPARATOR
Intervention: Higher healthcare referral region hospice rates
Number of subjects: 24342

Group type: COMPARATOR
Intervention: Black, non-Hispanic decedents
Number of subjects: 24342
Study: 34058616

Group type: EXPERIMENTAL
Intervention: Active range of motion (AROM)
Number of subjects: 164

Group type: EXPERIMENTAL
Intervention: Rotator cuff function
Number of subjects: 164

Group type: EXPERIMENTAL
Intervention: Scapular kinematics
Number of subjects: 164

Group type: EXPERIMENTAL
Intervention: Clinical presentation
Number of subjects: 164

Group type: EXPERIMENTAL
Intervention: Associations between clinical presentation and daily life impact
Number of subjects: 164
Study: 32066505

Group type: EXPERIMENTAL
Intervention: Outpatient balloon catheter induction
Number of subjects: 1552

Group type: COMPARATOR
Intervention: In-hospital prostaglandin induction
Number of subjects: 1552
Study: 34747997

Group type: EXPERIMENTAL
Intervention: Interactive messages three times a week for 4 weeks
Number of subjects: 375

Group type: EXPERIMENTAL
Intervention: Personalized, but not interactive messaging
Number of subjects: 375

Group type: EXPERIMENTAL
Intervention: Personalized and interactive messages three times a week for 2 weeks; then daily for 2 weeks
Number of subjects: 375

Group type: EXPERIMENTAL
Intervention: Two-way interactive messages
Number of subjects: 375

Group type: EXPERIMENTAL
Intervention: Constant or decreasing message frequency
Number of subjects: 375
Study: 35246089

Group type: EXPERIMENTAL
Intervention: HAP‐peptide suspension with NaOCl pre‐treatment (6.25 wt% HAP and 5 ml P11‐4 peptide, NaOCl 3%)
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: HAP (6.25 wt%)
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: P11‐4 peptide (5 ml)
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: NaOCl (3%)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Water (control group)
Number of subjects: 52
Study: 33165879

Group type: EXPERIMENTAL
Intervention: 1 mg/kg of lidocaine
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: 1.5 mg/kg of lidocaine
Number of subjects: 90

Group type: COMPARATOR
Intervention: Normal saline (NS)
Number of subjects: 90
Study: 35251574

Group type: EXPERIMENTAL
Intervention: HE‐LSTM model intervention
Number of subjects: 76

Group type: COMPARATOR
Intervention: Conventional group
Number of subjects: 76
Study: 34269480

Group type: EXPERIMENTAL
Intervention: LOVED program
Number of subjects: 48
Study: 33144344

Group type: EXPERIMENTAL
Intervention: Low carbohydrate diet
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 35210504

Group type: EXPERIMENTAL
Intervention: Music therapy (MG)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Standard care (CG)
Number of subjects: 40
Study: 32722609

Group type: EXPERIMENTAL
Intervention: Whey protein supplementation
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Carbohydrate supplementation
Number of subjects: 90

Group type: COMPARATOR
Intervention: Placebo (control)
Number of subjects: 90
Study: 36414775

Group type: EXPERIMENTAL
Intervention: CM for PrEP/ART adherence
Number of subjects: 19

Group type: COMPARATOR
Intervention: CM for MA abstinence
Number of subjects: 19
Study: 34444590

Group type: EXPERIMENTAL
Intervention: Nature video
Number of subjects: 506

Group type: COMPARATOR
Intervention: Built video
Number of subjects: 506
Study: 34578868

Group type: EXPERIMENTAL
Intervention: DIANA-5 dietary intervention based on Mediterranean diet and macrobiotic principles
Number of subjects: 1344

Group type: EXPERIMENTAL
Intervention: Increased recommended foods consumption
Number of subjects: 1344

Group type: EXPERIMENTAL
Intervention: Reduced discouraged foods consumption
Number of subjects: 1344

Group type: EXPERIMENTAL
Intervention: Higher category of dietary change
Number of subjects: 1344

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 1344
Study: 33017219

Group type: EXPERIMENTAL
Intervention: Hypothyroidism group
Number of subjects: 61

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 61
Study: 32528650

Group type: EXPERIMENTAL
Intervention: Haloperidol + Promethazine + Chlorpromazine (HPC)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Haloperidol + Promethazine (HP)
Number of subjects: 0
Study: 35038429

Group type: EXPERIMENTAL
Intervention: Sugemalimab 1200 mg intravenously every 3 weeks for up to 24 months
Number of subjects: 381

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 381

Group type: EXPERIMENTAL
Intervention: Sugemalimab
Number of subjects: 381
Study: 32223645

Group type: EXPERIMENTAL
Intervention: Biceps tenodesis
Number of subjects: 114

Group type: COMPARATOR
Intervention: Biceps tenotomy
Number of subjects: 114
Study: 36120830

Group type: EXPERIMENTAL
Intervention: Patisiran
Number of subjects: 225

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 225
Study: 35636727

Group type: EXPERIMENTAL
Intervention: Spironolactone
Number of subjects: 1767

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1767

Group type: EXPERIMENTAL
Intervention: CV hospitalization
Number of subjects: 1767

Group type: EXPERIMENTAL
Intervention: non-CV hospitalization
Number of subjects: 1767

Group type: EXPERIMENTAL
Intervention: Recurrent hospitalization for CV reasons
Number of subjects: 1767

Group type: EXPERIMENTAL
Intervention: Recurrent hospitalization for non-CV reasons
Number of subjects: 1767

Group type: EXPERIMENTAL
Intervention: Recurrent hospitalization for both CV and non-CV reasons
Number of subjects: 1767
Study: 33677616

Group type: EXPERIMENTAL
Intervention: 4 h HDMTX infusion (12 g/m2)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: 12 h HDMTX infusion (12 g/m2)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Comparison of 4 h and 12 h infusions
Number of subjects: 12
Study: 33196744

Group type: EXPERIMENTAL
Intervention: Combination of tissue stabilized guided subcision, microfocused ultrasound, and calcium hydroxylapatite injections
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Concomitant microfocused ultrasound and calcium hydroxylapatite injections followed by tissue stabilized guided subcision
Number of subjects: 61
Study: 35237030

Group type: EXPERIMENTAL
Intervention: Cortical Bone Trajectory (CBT) screw fixation
Number of subjects: 124

Group type: COMPARATOR
Intervention: Traditional Pedicle Screw (PS) fixation
Number of subjects: 124
Study: 34370833

Group type: EXPERIMENTAL
Intervention: 3D simulation
Number of subjects: 117

Group type: EXPERIMENTAL
Intervention: 2D photographs
Number of subjects: 117

Group type: COMPARATOR
Intervention: Standard care (verbal description alone)
Number of subjects: 117
Study: 33730398

Group type: EXPERIMENTAL
Intervention: IAC + RT (4 IAC bouts followed by 3 sets of 12 repetitions of 3 lower-limb free-weight exercises)
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: IAC + RT
Number of subjects: 66

Group type: COMPARATOR
Intervention: IAC + IAC (4 + 1 bouts of 4 min at 90% of HRMAX of intense aerobic cycling)
Number of subjects: 66

Group type: COMPARATOR
Intervention: IAC + IAC
Number of subjects: 66
Study: 32603006

Group type: EXPERIMENTAL
Intervention: 1064-nm neodymium-doped yttrium aluminum garnet picosecond laser using a diffractive optical element (P-DOE)
Number of subjects: 25

Group type: COMPARATOR
Intervention: non-ablative fractional laser (NAFL)
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: P-DOE
Number of subjects: 25
Study: 34378238

Group type: EXPERIMENTAL
Intervention: Tacrolimus + tripterygium glycosides
Number of subjects: 279

Group type: EXPERIMENTAL
Intervention: Tacrolimus
Number of subjects: 279

Group type: COMPARATOR
Intervention: Control group (standard therapy)
Number of subjects: 279
Study: 32066380

Group type: EXPERIMENTAL
Intervention: Individual Placement and Support (IPS) supported employment
Number of subjects: 119

Group type: COMPARATOR
Intervention: Treatment-as-usual vocational rehabilitation (TAU‐VR)
Number of subjects: 119
Study: 35134906

Group type: EXPERIMENTAL
Intervention: Teen Council peer education program
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study: 34318912

Group type: EXPERIMENTAL
Intervention: Heat therapy for 25 minutes, two times (at 1-hour interval)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Cold therapy for 25 minutes, two times (at 1-hour interval)
Number of subjects: 75

Group type: COMPARATOR
Intervention: Control group (no heat or cold therapy)
Number of subjects: 75
Study: 32884241

Group type: EXPERIMENTAL
Intervention: Rocuronium 0.6 mg/kg
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Rocuronium 1.2 mg/kg
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Rocuronium
Number of subjects: 90

Group type: COMPARATOR
Intervention: Normal saline (Control group S)
Number of subjects: 90
Study: 35488192

Group type: EXPERIMENTAL
Intervention: Sufentanil (0.35 µg/kg)
Number of subjects: 107

Group type: COMPARATOR
Intervention: Fentanyl (3.5 µg/kg)
Number of subjects: 107
Study: 34128721

Group type: EXPERIMENTAL
Intervention: DECTA with 300 mg of iodine per kilogram by using an optimized threshold
Number of subjects: 96

Group type: COMPARATOR
Intervention: Conventional DECTA with 300 mg of iodine per kilogram using a conventional threshold
Number of subjects: 96

Group type: COMPARATOR
Intervention: SECTA with standard iodine dose (600 mg of iodine per kilogram)
Number of subjects: 96
Study: 32897369

Group type: EXPERIMENTAL
Intervention: Iodophor
Number of subjects: 0

Group type: COMPARATOR
Intervention: Chlorhexidine
Number of subjects: 0
Study: 34705101

Group type: EXPERIMENTAL
Intervention: Fractional Er: YAG laser plus Kligman's formula
Number of subjects: 20

Group type: COMPARATOR
Intervention: Kligman's formula alone
Number of subjects: 20
Study: 32216870

Group type: EXPERIMENTAL
Intervention: Dementia Care Mapping™ (DCM) intervention
Number of subjects: 726

Group type: COMPARATOR
Intervention: Usual care (control)
Number of subjects: 726
Study: 35751421

Group type: EXPERIMENTAL
Intervention: Extended-field irradiation (EFI)
Number of subjects: 288

Group type: COMPARATOR
Intervention: Pelvic radiotherapy (PRT)
Number of subjects: 288

Group type: EXPERIMENTAL
Intervention: Extended-field irradiation (EFI) in CA9-only positive subgroup
Number of subjects: 288

Group type: EXPERIMENTAL
Intervention: Extended-field irradiation (EFI) in CA9/HIFs double positive subgroup
Number of subjects: 288

Group type: EXPERIMENTAL
Intervention: RNA-seq analysis
Number of subjects: 288
Study: 32862713

Group type: EXPERIMENTAL
Intervention: Telemonitoring intervention (TI) group
Number of subjects: 450

Group type: COMPARATOR
Intervention: Usual care (UC) group
Number of subjects: 450
Study: 37721178

Group type: EXPERIMENTAL
Intervention: Glycine diet (30 g glycine per 1 kg meat)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Control diet (horse meat only)
Number of subjects: 10
Study: 34450475

Group type: EXPERIMENTAL
Intervention: Cabazitaxel (25 mg/m2 every 3 weeks)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Abiraterone (1000 mg/day) or Enzalutamide (160 mg/day)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cabazitaxel
Number of subjects: 0

Group type: COMPARATOR
Intervention: Abiraterone or Enzalutamide
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: NLR (continuous covariate)
Number of subjects: 0
Study: 33175279

Group type: EXPERIMENTAL
Intervention: Protaper Universal (PTU)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Hero Shaper (HS)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Hyflex CM (HCM)
Number of subjects: 27
Study: 35620797

Group type: EXPERIMENTAL
Intervention: Caregivers with insomnia symptoms
Number of subjects: 57
Study: 34550084

Group type: EXPERIMENTAL
Intervention: Web-based integrated management program
Number of subjects: 231

Group type: COMPARATOR
Intervention: Usual care (control)
Number of subjects: 231
Study: 32822246

Group type: EXPERIMENTAL
Intervention: Correct helmet use with enforcement presence (camera or police personnel)
Number of subjects: 77932

Group type: COMPARATOR
Intervention: Incorrect helmet use
Number of subjects: 77932

Group type: EXPERIMENTAL
Intervention: Correct helmet use
Number of subjects: 77932

Group type: EXPERIMENTAL
Intervention: Presence of enforcement
Number of subjects: 77932
Study: 33165503

Group type: EXPERIMENTAL
Intervention: Medium Dose (MD) of the vaccine
Number of subjects: 742

Group type: EXPERIMENTAL
Intervention: High Dose (HD) of the vaccine
Number of subjects: 742

Group type: EXPERIMENTAL
Intervention: Medium Dose (MD) of the vaccine with 28 days interval
Number of subjects: 742

Group type: EXPERIMENTAL
Intervention: High Dose (HD) of the vaccine with 28 days interval
Number of subjects: 742

Group type: COMPARATOR
Intervention: Placebo (Control)
Number of subjects: 742
Study: 32689601

Group type: EXPERIMENTAL
Intervention: Robotic Rehabilitation group with VR (RRG+VR)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Robotic Rehabilitation group without VR (RRG‐VR)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Conventional Rehabilitation group (CRG)
Number of subjects: 90
Study: 34521604

Group type: EXPERIMENTAL
Intervention: Home Usability Program
Number of subjects: 195

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 195
Study: 32922524

Group type: EXPERIMENTAL
Intervention: Topical diclofenac diethylamine 2.32% w/w gel, applied every 12 hours for 7 days before surgery
Number of subjects: 47

Group type: COMPARATOR
Intervention: Placebo gel, applied every 12 hours for 7 days before surgery
Number of subjects: 47
Study: 35597980

Group type: EXPERIMENTAL
Intervention: rhPTX-2 treatment (10 mg/kg intravenous infusions on Days 1, 3, and 5 in the first week of each 28-week cycle, then one infusion every 4 weeks up to Week 128)
Number of subjects: 111

Group type: EXPERIMENTAL
Intervention: rhPTX-2 treatment
Number of subjects: 111
Study: 33647103

Group type: EXPERIMENTAL
Intervention: Distraction (phone ring and brief conversation during vignette)
Number of subjects: 88

Group type: COMPARATOR
Intervention: Non-distracted (no distraction during vignette)
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Distraction (questions after distraction)
Number of subjects: 88

Group type: COMPARATOR
Intervention: Non-distracted (questions after distraction)
Number of subjects: 88
Study: 33060497

Group type: EXPERIMENTAL
Intervention: Foot massage (3 sessions a week, 20 minutes each for 4 weeks)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 34379701

Group type: EXPERIMENTAL
Intervention: Higher plasma free thiol levels at Day 1
Number of subjects: 217

Group type: EXPERIMENTAL
Intervention: Higher plasma free thiol levels at Day 5
Number of subjects: 217

Group type: EXPERIMENTAL
Intervention: Plasma free thiol levels at 30 minutes and 90 minutes
Number of subjects: 217
Study: 33045376

Group type: EXPERIMENTAL
Intervention: Single triangle frontalis suspension using ePTFE suture
Number of subjects: 60

Group type: COMPARATOR
Intervention: Fox pentagon frontalis suspension using ePTFE suture
Number of subjects: 60
Study: 36335976

Group type: EXPERIMENTAL
Intervention: Fee for home delivery and monitoring of ART
Number of subjects: 162

Group type: COMPARATOR
Intervention: Clinic-based ART (standard of care)
Number of subjects: 162
Study: 33252440

Group type: EXPERIMENTAL
Intervention: Brief counseling (inpatient counseling)
Number of subjects: 266

Group type: EXPERIMENTAL
Intervention: Extended counseling (brief counseling plus follow‐up counseling)
Number of subjects: 266

Group type: COMPARATOR
Intervention: Control (no counseling)
Number of subjects: 266

Group type: EXPERIMENTAL
Intervention: Extended counseling
Number of subjects: 266

Group type: EXPERIMENTAL
Intervention: Brief counseling
Number of subjects: 266
Study: 32371520

Group type: EXPERIMENTAL
Intervention: RECOVER model
Number of subjects: 890

Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 890
Study: 36265942

Group type: EXPERIMENTAL
Intervention: Low-dose Paclitaxel-Coated Balloon (Ranger)
Number of subjects: 414

Group type: EXPERIMENTAL
Intervention: High-dose Paclitaxel-Coated Balloon (IN.PACT)
Number of subjects: 414